Browse > Article
http://dx.doi.org/10.4062/biomolther.2017.082

Imperatorin is Transported through Blood-Brain Barrier by Carrier-Mediated Transporters  

Tun, Temdara (College of Pharmacy, Drug Information Research Institute and Research Center for Cell Fate Control, Sookmyung Women's University)
Kang, Young-Sook (College of Pharmacy, Drug Information Research Institute and Research Center for Cell Fate Control, Sookmyung Women's University)
Publication Information
Biomolecules & Therapeutics / v.25, no.4, 2017 , pp. 441-451 More about this Journal
Abstract
Imperatorin, a major bioactive furanocoumarin with multifunctions, can be used for treating neurodegenerative diseases. In this study, we investigated the characteristics of imperatorin transport in the brain. Experiments of the present study were designed to study imperatorin transport across the blood-brain barrier both in vivo and in vitro. In vivo study was performed in rats using single intravenous injection and in situ carotid artery perfusion technique. Conditionally immortalized rat brain capillary endothelial cells were as an in vitro model of blood-brain barrier to examine the transport mechanism of imperatorin. Brain distribution volume of imperatorin was about 6 fold greater than that of sucrose, suggesting that the transport of imperatorin was through the blood-brain barrier in physiological state. Both in vivo and in vitro imperatorin transport studies demonstrated that imperatorin could be transported in a concentration-dependent manner with high affinity. Imperatorin uptake was dependent on proton gradient in an opposite direction. It was significantly reduced by pretreatment with sodium azide. However, its uptake was not inhibited by replacing extracellular sodium with potassium or N-methylglucamine. The uptake of imperatorin was inhibited by various cationic compounds, but not inhibited by TEA, choline and organic anion substances. Transfection of plasma membrane monoamine transporter, organic cation transporter 2 and organic cation/carnitine transporter 2/1 siRNA failed to alter imperatorin transport in brain capillary endothelial cells. Especially, tramadol, clonidine and pyrilamine inhibited the uptake of [$^3H$]imperatorin competitively. Therefore, imperatorin is actively transported from blood to brain across the blood-brain barrier by passive and carrier-mediated transporter.
Keywords
Imperatorin; Alzheimer's disease; Blood-brain barrier; Proton coupled antiporter;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Stavri, M. and Gibbons, S. (2005) The antimycobacterial constituents of dill (Anethum graveolens). Phytother. Res. 19, 938-941.   DOI
2 Budzynska, B., Boguszewska-Czubara, A., Kruk-Slomka, M., Skalicka-Wozniak, K., Michalak, A., Musik, I. and Biala, G. (2015) Effects of imperatorin on scopolamine-induced cognitive impairment and oxidative stress in mice. Psychopharmacology (Berl.) 232, 931-942.   DOI
3 Budzynska, B., Kruk-Slomka, M., Skalicka-Wozniak, K., Biala, G. and Glowniak, K. (2012) The effects of imperatorin on anxiety and memory-related behavior in male Swiss mice. Exp. Clin. Psychopharmacol. 20, 325-332.   DOI
4 Chapy, H., Smirnova, M., Andre, P., Schlatter, J., Chiadmi, F., Couraud, P. O., Scherrmann, J. M., Decleves, X. and Cisternino, S. (2014) Carrier-mediated cocaine transport at the blood-brain barrier as a putative mechanism in addiction liability. Int. J. Neuropsychopharmacol. 18, pyu001.
5 Chapy, H., Goracci, L., Vayer, P., Parmentier, Y., Carrupt, P. A., Decleves, X., Scherrmann, J. M., Cisternino, S. and Cruciani, G. (2015) Pharmacophore-based discovery of inhibitors of a novel drug/proton antiporter in human brain endothelial hCMEC/D3 cell line. Br. J. Pharmacol. 172, 4888-4904.   DOI
6 Cisternino, S., Chapy, H., Andre, P., Smirnova, M., Debray, M. and Scherrmann, J. M. (2013) Coexistence of passive and proton antiporter-mediated processes in nicotine transport at the mouse blood-brain barrier. AAPS J. 15, 299-307.   DOI
7 Deguchi, Y., Yokoyama, Y., Sakamoto, T., Hayashi, H., Naito, T., Yamada, S. and Kimura, R. (2000) Brain distribution of 6-mercaptopurine is regulated by the efflux transport system in the blood-brain barrier. Life.Sci. 66, 649-662.   DOI
8 Suzuki, T., Moriki, Y., Goto, H., Tomono, K., Hanano, M. and Watanabe, J. (2002) Investigation on the influx transport mechanism of pentazocine at the blood-brain barrier in rats using the carotid injection technique. Biol. Pharm. Bull. 25, 1351-1355.   DOI
9 Takasato, Y., Rapoport, S. I. and Smith, Q. R. (1984) An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am. J. Physiol. 247, H484-H493.
10 Tamai, I., Nakanishi, T., Kobayashi, D., China, K., Kosugi, Y., Nezu, J., Sai, Y. and Tsuji, A. (2004) Involvement of OCTN1 (SLC22A4) in pH-dependent transport of organic cations. Mol. Pharm. 1, 57-66.   DOI
11 Tega, Y., Akanuma, S., Kubo, Y., Terasaki, T. and Hosoya, K. (2013) Blood-to-brain influx transport of nicotine at the rat blood-brain barrier: involvement of a pyrilamine-sensitive organic cation transport process. Neurochem. Int. 62, 173-181.   DOI
12 Terada, T. and Inui, K. (2008) Physiological and pharmacokinetic roles of H+/organic cation antiporters (MATE/SLC47A). Biochem. Pharmacol. 75, 1689-1696.   DOI
13 Terasaki, T. and Hosoya, K. (2001) Conditionally immortalized cell lines as a new in vitro model for the study of barrier functions. Biol. Pharm. Bull. 24, 111-118.   DOI
14 Wu, D., Kang, Y. S., Bickel, U. and Pardridge, W. M. (1997) Bloodbrain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine. Drug Metab. Dispos. 25, 768-771.
15 Wu, D. and Pardridge, W. M. (1999) Blood-brain barrier transport of reduced folic acid. Pharm. Res. 16, 415-419.   DOI
16 Sancho, R., Marquez, N., Gomez-Gonzalo, M., Calzado, M. A., Bettoni, G., Coiras, M. T., Alcami, J., Lopez-Cabrera, M., Appendino, G. and Munoz, E. (2004) Imperatorin inhibits HIV-1 replication through an Sp1-dependent pathway. J. Biol. Chem. 279, 37349-37359.   DOI
17 Fujii, S., Hayashi, H., Itoh, K., Yamada, S., Deguchi, Y. and Kawazu, K. (2013) Characterization of the carrier-mediated transport of ketoprofen, a nonsteroidal anti-inflammatory drug, in rabbit corneal epithelium cells. J. Pharm. Pharmacol. 65, 171-180.   DOI
18 Roth, M., Obaidat, A. and Hagenbuch, B. (2012) OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies. Br. J. Pharmacol. 165, 1260-1287.   DOI
19 Sadiq, M. W., Borgs, A., Okura, T., Shimomura, K., Kato, S., Deguchi, Y., Jansson, B., Bjorkman, S., Terasaki, T. and Hammarlund-Udenaes, M. (2011) Diphenhydramine active uptake at the blood-brain barrier and its interaction with oxycodone in vitro and in vivo. J. Pharm. Sci. 100, 3912-3923.   DOI
20 Sai, Y., Kaneko, Y., Ito, S., Mitsuoka, K., Kato, Y., Tamai, I., Artursson, P. and Tsuji, A. (2006) Predominant contribution of organic anion transporting polypeptide OATP-B (OATP2B1) to apical uptake of estrone-3-sulfate by human intestinal Caco-2 cells. Drug Metab. Dispos. 34, 1423-1431.   DOI
21 Senol, F. S., Wozniak, K. S., Khan, M. T. H., Orhan, I. E., Sener, B. and Glowniak, K. (2011) An in vitro and in silico approach to cholinesterase inhibitory and antioxidant effects of the methanol extract, furanocoumarin fraction, and major coumarins of Angelica officinalis L. fruits. Phytochem. Lett. 4, 462-467.   DOI
22 Shimomura, K., Okura, T., Kato, S., Couraud, P. O., Schermann, J. M., Terasaki, T. and Deguchi, Y. (2013) Functional expression of a proton-coupled organic cation (H+/OC) antiporter in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model. Fluids Barriers CNS 10, 8.   DOI
23 Sigurdsson, S. and Gudbjarnason, S. (2007) Inhibition of acetylcholinesterase by extracts and constituents from Angelica archangelica and Geranium sylvaticum. Z. Naturforsch., C, J. Biosci. 62, 689-693.
24 Kang, Y. S., Ohtsuki, S., Takanaga, H., Tomi, M., Hosoya, K. and Terasaki, T. (2002) Regulation of taurine transport at the blood-brain barrier by tumor necrosis factor-alpha, taurine and hypertonicity. J. Neurochem. 83, 1188-1195.   DOI
25 Hosoya, K., Makihara, A., Tsujikawa, Y., Yoneyama, D., Mori, S., Terasaki, T., Akanuma, S., Tomi, M. and Tachikawa, M. (2009) Roles of inner blood-retinal barrier organic anion transporter 3 in the vitreous/retina-to-blood efflux transport of p-aminohippuric acid, benzylpenicillin, and 6-mercaptopurine. J. Pharmacol. Exp. Ther. 329, 87-93.   DOI
26 Hiasa, M., Matsumoto, T., Komatsu, T., Omote H. and Moriyama, Y. (2007) Functional characterization of testis-specific rodent multidrug and toxic compound extrusion 2, a class III MATE-type polyspecific H+/organic cation exporter. Am. J. Physiol., Cell Physiol. 293, C1437-C1444.   DOI
27 Kang, Y. S., Lee, K. E., Lee, N. Y. and Terasaki, T. (2005) Donepezil, tacrine and alpha-phenyl-n-tert-butyl nitrone (PBN) inhibit choline transport by conditionally immortalized rat brain capillary endothelial cell lines (TR-BBB). Arch. Pharm. Res. 28, 443-450.   DOI
28 Kang, Y. S. (2000) Taurine transport mechanism through the bloodbrain barrier in spontaneously hypertensive rats. Adv. Exp. Med. Biol. 483, 321-324.
29 Kim, D. K., Lim, J. P., Yang, J. H., Eom, D. O., Eun, J. S. and Leem, K. H. (2002) Acetylcholinesterase inhibitors from the roots of Angelica dahurica. Arch. Pharm. Res. 25, 856-859.   DOI
30 Kido, Y., Tamai, I., Ohnari, A., Sai, Y., Kagami, T., Nezu, J., Nikaido, H., Hashimoto, N., Asano, M. and Tsuji, A. (2001) Functional relevance of carnitine transporter OCTN2 to brain distribution of Lcarnitine and acetyl-L-carnitine across the blood-brain barrier. J. Neurochem. 79, 959-969.
31 Kitamura, A., Higuchi, K., Okura, T. and Deguchi, Y. (2014) Transport characteristics of tramadol in the blood-brain barrier. J. Pharm. Sci. 103, 3335-3341.   DOI
32 Lee, N. Y., Sai, Y., Nakashima, E., Ohtsuki, S. and Kang, Y. S. (2011) 6-Mercaptopurine transport by equilibrative nucleoside transporters in conditionally immortalized rat syncytiotrophoblast cell lines TR-TBTs. J. Pharm. Sci. 100, 3773-3782.   DOI
33 Zhang, X., Xie, Y., Cao, W., Qian, Y., Shan, M. and Siwang, W. (2011) Brain distribution study of imperatorin in rats after oral administration assessed by HPLC. Chromatographia 74, 259-265.   DOI
34 Koepsell, H., Lips, K. and Volk C. (2007) Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm. Res. 24, 1227-1251.   DOI
35 Koziol, E. and Skalicka-Wozniak, K. (2016) Imperatorin-pharmacological meaning and analytical clues: profound investigation. Phytochem. Rev. 15, 627-649.   DOI
36 Kubo, Y., Kusagawa, Y., Tachikawa, M., Akanuma, S. and Hosoya, K. (2013) Involvement of a novel organic cation transporter in verapamil transport across the inner blood-retinal barrier. Pharm. Res. 30, 847-856.   DOI
37 Lee, E., Choi, S. Y., Yang, J. H. and Lee, Y. J. (2016) Preventive effects of imperatorin on perfluorohexanesulfonate-induced neuronal apoptosis via inhibition of intracellular calcium-mediated ERK pathway. Korean J. Physiol. Pharmacol. 20, 399-406.   DOI
38 Lee, N. Y., Lee, K. B. and Kang, Y. S. (2014) Pharmacokinetics, placenta, and brain uptake of paclitaxel in pregnant rats. Cancer Chemother. Pharmacol. 73, 1041-1045.   DOI
39 Lee, N. Y. and Kang, Y. S. (2016) In vivo and in vitro evidence for brain uptake of 4-Phenylbutyrate by the monocarboxylate transporter 1 (MCT1). Pharm. Res. 33, 1711-1722.   DOI
40 Lili, W., Yehong, S., Qi, Y., Yan, H., Jinhui, Z., Yan, L. and Cheng, G. (2013) In vitro permeability analysis, pharmacokinetic and brain distribution study in mice of imperatorin, isoimperatorin and cnidilin in Radix Angelicae Dahuricae. Fitoterapia 85, 144-153.   DOI
41 Ohta, K. Y., Inoue, K., Hayashi, Y. and Yuasa, H. (2006) Molecular identification and functional characterization of rat multidrug and toxin extrusion type transporter 1 as an organic cation/H+ antiporter in the kidney. Drug Metab. Dispos. 34, 1868-1874.   DOI
42 Abad, M. J., de las Heras, B., Silvan, A. M., Pascual, R., Bermejo, P., Rodriquez, B. and Villar, A. M. (2001) Effects of furocoumarins from Cachrys trifida on some macrophage functions. J. Pharm. Pharmacol. 53, 1163-1168.   DOI
43 Andre, P., Debray, M., Scherrmann, J. M. and Cisternino, S. (2009) Clonidine transport at the mouse blood-brain barrier by a new H+ antiporter that interacts with addictive drugs. J. Cereb. Blood Flow Metab. 29, 1293-1304.   DOI
44 Baek, N. I., Ahn, E. M., Kim, H. Y. and Park, Y. D. (2000) Furanocoumarins from the root of Angelica dahurica. Arch. Pharm. Res. 23, 467-470.   DOI
45 Miecz, D., Januszewicz, E., Czeredys, M., Hinton, B. T., Berezowski, V., Cecchelli, R. and Nalecz, K. A. (2008) Localization of organic cation/carnitine transporter (OCTN2) in cells forming the bloodbrain barrier. J. Neurochem. 104, 113-123.
46 Mori, S., Ohtsuki, S., Takanaga, H., Kikkawa, T., Kang, Y. S. and Terasaki, T. (2004) Organic anion transporter 3 is involved in the brain-to-blood efflux transport of thiopurine nucleobase analogs. J. Neurochem. 90, 931-941.   DOI
47 Ohtsuki, S. and Terasaki, T. (2007) Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development. Pharm. Res. 24, 1745-1758.   DOI
48 Pardridge, W. M., Kang, Y. S. and Buciak, J. (1994) Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery. Pharm. Res. 11, 738-746.   DOI
49 Okura, T., Hattori, A., Takano, Y., Sato, T., Hammarlund-Udenaes, M., Terasaki, T. and Deguchi, Y. (2008) Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone. Drug Metab. Dispos. 36, 2005-2013.   DOI
50 Okura, T., Kato, S., Takano, Y., Sato, T., Yamashita, A., Morimoto, R., Ohtsuki, S., Terasaki, T. and Deguchi, Y. (2011) Functional characterization of rat plasma membrane monoamine transporter in the blood-brain and blood-cerebrospinal fluid barriers. J. Pharm. Sci. 100, 3924-3938.   DOI